Based on the above and taking into account the limitations of the study performed, which was based exclusively on in vitro data, ongoing study and in vivo validation of potential biomarkers and the mechanisms of response to HSP90 inhibition in lung adenocarcinoma proposed here are required to substantiate their importance. This evidence concerns the gene HSP90AB1 and lung adenocarcinoma.